AD |
Alzheimer’s disease |
Aβ |
amyloid β |
mTOR |
mechanistic target of rapamycin kinase |
SGLT2 |
sodium glucose cotransporter 2 |
APP/PS1 mice |
double transgenic mouse model of Alzheimer’s disease over expressing amyloid precursor protein, encoding the Swedish mutations at amino acids 595/596 and an exon-9-deleted human PS1 |
Tg2576 mice |
transgenic mouse model, which express a 695-aa residue splice form of human amyloid precursor protein modified by the Swedish Familial AD double mutation K670N-M671L |
3xTg-AD mice |
triple-transgenic mouse model harboring PS1M146V, APPSwe, and tauP301L transgenes |
ATP |
adenosine triphosphate |
MAPT |
microtubule associated protein tau |
ROS |
reactive oxygen species |
IDE |
insulin-degrading enzymes |
APP |
amyloid precursor protein |
TZDs |
thiazolidinediones |
GLP1 |
glucagon-like peptide-1 |
DPP-4 |
dipeptidyl peptidase-4 |
IGF-1 |
insulin-like growth factor-1 |
PS1 |
presenilin 1 |
PS 2 |
presenilin 2 |
APOE |
Apolipoprotein E |
PPARs |
peroxisome proliferator-activated receptors |
AChE |
acetylcholinesterase |
AMPK |
adenosine 5′mmonophosphate-activated protein kinase |
PPARs |
peroxisome proliferator-activated receptors |
PI3K |
phosphatidylinositol-3-OH kinase |
IRS-2 |
insulin receptor-2 |
NLRP3 |
nod-like receptor pyrin domain containing 3 |